Apollo.io
CatalystAlert
CatalystAlert
Briefing
Calendar
IPOs
Opportunities
Companies
Compare
Analytics
Watchlist

Search...
Search CatalystAlert
Search for companies, drugs, and catalysts

Search CatalystAlert
Search for companies, drugs, and catalysts


Toggle theme
Sign In
Top Gainers
(24h)
#1
LPTX
$2.05
+368.57%
#2
NBY
$19.16
+183.85%
#3
ZVSA
$0.27
+65.63%
#4
AGL
$0.99
+43.26%
#5
VXRT
$0.68
+41.67%
#6
CHTH
$5.21
+38.93%
#7
ZNTL
$3.74
+31.69%
#8
CGON
$54.20
+29.26%
#9
SLRX
$0.84
+29.23%
#10
MLTX
$18.49
+28.94%
#1
LPTX
$2.05
+368.57%
#2
NBY
$19.16
+183.85%
#3
ZVSA
$0.27
+65.63%
#4
AGL
$0.99
+43.26%
#5
VXRT
$0.68
+41.67%
#6
CHTH
$5.21
+38.93%
#7
ZNTL
$3.74
+31.69%
#8
CGON
$54.20
+29.26%
#9
SLRX
$0.84
+29.23%
#10
MLTX
$18.49
+28.94%
#1
LPTX
$2.05
+368.57%
#2
NBY
$19.16
+183.85%
#3
ZVSA
$0.27
+65.63%
#4
AGL
$0.99
+43.26%
#5
VXRT
$0.68
+41.67%
#6
CHTH
$5.21
+38.93%
#7
ZNTL
$3.74
+31.69%
#8
CGON
$54.20
+29.26%
#9
SLRX
$0.84
+29.23%
#10
MLTX
$18.49
+28.94%

Top Losers
(24h)
#1
SXTC
$0.15
-87.92%
#2
PASW
$0.20
-67.65%
#3
SONN
$1.26
-59.35%
#4
MHUA
$7.61
-45.72%
#5
AQST
$3.91
-37.04%
#6
ATRA
$13.67
-21.62%
#7
GRI
$0.23
-20.77%
#8
PRQR
$1.77
-15.71%
#9
ESLA
$1.20
-14.89%
#10
CDIO
$2.05
-14.58%
#1
SXTC
$0.15
-87.92%
#2
PASW
$0.20
-67.65%
#3
SONN
$1.26
-59.35%
#4
MHUA
$7.61
-45.72%
#5
AQST
$3.91
-37.04%
#6
ATRA
$13.67
-21.62%
#7
GRI
$0.23
-20.77%
#8
PRQR
$1.77
-15.71%
#9
ESLA
$1.20
-14.89%
#10
CDIO
$2.05
-14.58%
#1
SXTC
$0.15
-87.92%
#2
PASW
$0.20
-67.65%
#3
SONN
$1.26
-59.35%
#4
MHUA
$7.61
-45.72%
#5
AQST
$3.91
-37.04%
#6
ATRA
$13.67
-21.62%
#7
GRI
$0.23
-20.77%
#8
PRQR
$1.77
-15.71%
#9
ESLA
$1.20
-14.89%
#10
CDIO
$2.05
-14.58%
Analytics Dashboard
Industry success rates, pipeline rankings, and therapeutic area insights. Press ? for keyboard shortcuts.

Catalysts
51

Companies
1,311

Drug Programs
8,113

This Week
8


Next 30 days
Insights
Pipeline
Therapeutic
Heatmap
AI

?
AI Prediction System
Machine learning models for biotech catalyst analysis
Online
System Status

XGBoost

Impact Model

xgb-v20260111_030112

Random Forest

LOA Model

rf-v202601090400

Impact Prediction
Predicts stock price direction (up/down/neutral) and magnitude based on catalyst type, phase, therapeutic area, and market conditions.

880+ catalyst patterns
3-class classification
Likelihood of Approval
Estimates FDA approval probability using phase, indication, trial design, and special designations (Breakthrough, Fast Track, Orphan).

BIO 2024 calibrated
Platt scaling
Upcoming Phase 3 & PDUFA Events
View predictions on individual company pages for detailed analysis
Phase 3
MRK
•
pembrolizumab
Non-small Cell Lung Cancer

Jan 11, 2026

Expected Date

View AI
Phase 3
AZN
•
Durvalumab
Non-Small Cell Lung Cancer

Jan 11, 2026

Expected Date

View AI
PDUFA
TVTX
•
FDA PDUFA Date sparsentan (priority)

Jan 12, 2026

Expected Date

View AI
Phase 3
BCTXZ
•
SV-BR-1-GM
Breastcancer

Jan 14, 2026

Expected Date

View AI
Phase 3
TBPH
•
ampreloxetine
Symptomatic Neurogenic Orthostatic Hypotension

Jan 14, 2026

Expected Date

View AI
Phase 3
PVLA
•
QTORIN 3.9% Rapamycin Anhydrous Gel
Microcystic Lymphatic Malformation

Jan 14, 2026

Expected Date

View AI
View all 10 events
How Our AI Works
1. Data Collection

Historical data from ClinicalTrials.gov, FDA decisions, and market outcomes

2. Feature Engineering

Phase, therapeutic area, designations, trial design, market conditions

3. Model Training

XGBoost for impact, Random Forest for LOA with probability calibration

4. Continuous Learning

Weekly retraining with new outcomes to improve accuracy

Predictions are for informational purposes only and NOT financial advice. Past performance does not guarantee future results.

C
CatalystAlert
Free biotech catalyst calendar with AI-powered predictions. Track FDA decisions, PDUFA dates, clinical trial results, and Phase 3 readouts. Real-time alerts for biotech investors.

Quick Links
This Week's Catalysts
Full Calendar
Catalyst Types
Search Companies
Biotech Glossary
Embed Widget
Legal
About
ML Track Record
Privacy
Terms
Data Sources
ClinicalTrials.gov
SEC EDGAR
FDA
⚠️ Not Financial Advice (NFA)

CatalystAlert provides data aggregation and analysis tools only. All probability scores and predictions are based on historical data and are NOT guarantees of future results. Past performance does not indicate future success. We are not responsible for the accuracy of third-party data sources. Always consult a qualified financial advisor before making investment decisions.

© 2026 CatalystAlert. All rights reserved.

Data may be delayed or incomplete. Use at your own risk.


Feedback
Biotech Analytics & AI Predictions | FDA Success Rates & ML Insights | CatalystAlert | CatalystAlert